{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:18:33Z","timestamp":1775315913204,"version":"3.50.1"},"reference-count":127,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Diabetes mellitus is found to be among the most suffered and lethal diseases for\nmankind. Diabetes mellitus type-1 is caused by the demolition of pancreatic islets responsible for\nthe secretion of insulin. Insulin is the peptide hormone (anabolic) that regulates the metabolism of\ncarbohydrates, fats, and proteins. Upon the breakdown of the natural process of metabolism, the\ncondition leads to hyperglycemia (increased blood glucose levels). Hyperglycemia demands outsourcing\nof insulin. The subcutaneous route was found to be the most stable route of insulin administration\nbut faces patient compliance problems. Oral Insulin delivery systems are the patient-centered\nand innovative novel drug delivery system, eliminating the pain caused by the subcutaneous\nroute of administration. Insulin comes in contact across various barriers in the gastrointestinal tract,\nwhich has been discussed in detail in this review. The review describes about the different bioengineered\nformulations, including microcarriers, nanocarriers, Self-Microemulsifying Drug Delivery\nSystems (SMEDDs), Self-Nanoemulsifying drug delivery systems (SNEDDs), polymeric micelles,\ncochleates, etc. Surface modification of the carriers is also possible by developing ligand anchored\nbioconjugates. A study on evaluation has shown that the carrier systems facilitate drug encapsulation\nwithout tampering the properties of insulin. Carrier-mediated transport by the use of natural,\nsemi-synthetic, and synthetic polymers have shown efficient results in drug delivery by protecting\ninsulin from harmful environment. This makes the formulation readily acceptable for a variety of\npopulations. The present review focuses on the properties, barriers present in the GI tract, overcome\nthe barriers, strategies to formulate oral insulin formulation by enhancing the stability and\nbioavailability of insulin.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201818666210720145706","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T19:32:15Z","timestamp":1626895935000},"page":"317-336","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Strategies to Improve Insulin Delivery through Oral Route: A Review"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2961-4108","authenticated-orcid":true,"given":"Gangadharappa","family":"H.V.","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Sri Shivarathreshwara\nNagara, Bannimantap, Mysuru-570015, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9055-6357","authenticated-orcid":true,"given":"Rohini","family":"Bhattacharya","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Sri Shivarathreshwara\nNagara, Bannimantap, Mysuru-570015, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0900-9143","authenticated-orcid":true,"given":"Asha P.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Sri Shivarathreshwara\nNagara, Bannimantap, Mysuru-570015, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1835-6294","authenticated-orcid":true,"given":"T.","family":"Shailesh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Sri Shivarathreshwara\nNagara, Bannimantap, Mysuru-570015, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8826-3718","authenticated-orcid":true,"given":"Mohamed","family":"Rahamathulla","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, College of Pharmacy, King Khalid University, Guraiger, Abha, 62529, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107734","volume":"107734","author":"Mandal N.","year":"2020","unstructured":"Mandal N.; Grambergs R.; Mondal K.; Basu S.K.; Tahia F.; Dagogo-Jack S.; Role of ceramides in the pathogenesis of diabetes mellitus and its complications. J Diabetes Complications 2020,107734","journal-title":"J Diabetes Complications"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jconrel.2017.09.003","volume":"264","author":"Wong C.Y.","year":"2017","unstructured":"Wong C.Y.; Al-Salami H.; Dass C.R.; Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment. J Control Release 2017,264,247-275","journal-title":"J Control Release"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijpharm.2017.12.036","volume":"537","author":"Wong C.Y.","year":"2018","unstructured":"Wong C.Y.; Al-Salami H.; Dass C.R.; Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin. Int J Pharm 2018,537(1-2),223-244","journal-title":"Int J Pharm"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"6134","DOI":"10.1021\/acs.jmedchem.0c00266","volume":"63","author":"Kabotso D.E.K.","year":"2020","unstructured":"Kabotso D.E.K.; Smiley D.; Mayer J.P.; Gelfanov V.M.; Perez-Tilve D.; DiMarchi R.D.; Pohl N.L.B.; Liu F.; Addition of sialic acid to insulin confers superior physical properties and bioequivalence. J Med Chem 2020,63(11),6134-6143","journal-title":"J Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mce.2015.08.013","volume":"415","author":"Bedinger D.H.","year":"2015","unstructured":"Bedinger D.H.; Adams S.H.; Metabolic, anabolic, and mitogenic insulin responses: A tissue-specific perspective for insulin receptor activators. Mol Cell Endocrinol 2015,415,143-156","journal-title":"Mol Cell Endocrinol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1016\/j.bbrc.2018.08.029","volume":"503","author":"Ferri G.","year":"2018","unstructured":"Ferri G.; Bugliani M.; Marchetti P.; Cardarelli F.; Probing the light scattering properties of insulin secretory granules in single live cells. Biochem Biophys Res Commun 2018,503(4),2710-2714","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/pedi.12358","volume":"17","author":"Biester T.","year":"2016","unstructured":"Biester T.; Danne T.; Bl\u00e4sig S.; Remus K.; Aschemeier B.; Kordonouri O.; Bardtrum L.; Haahr H.; Pharmacokinetic and prandial pharmacodynamic properties of insulin degludec\/insulin aspart in children, adolescents, and adults with type 1 diabetes. Pediatr Diabetes 2016,17(8),642-649","journal-title":"Pediatr Diabetes"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/1932296816658055","volume":"11","author":"Heinemann L.","year":"2017","unstructured":"Heinemann L.; Baughman R.; Boss A.; Hompesch M.; Pharmacokinetic and Pharmacodynamic Properties of a Novel Inhaled Insulin. J Diabetes Sci Technol 2017,11(1),148-156","journal-title":"J Diabetes Sci Technol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fendo.2016.00004","volume":"7","author":"Abdulrahman A.O.","year":"2016","unstructured":"Abdulrahman A.O.; Ismael M.A.; Al-Hosaini K.; Rame C.; Al-Senaidy A.M.; Dupont J.; Ayoub M.A.; Differential effects of camel milk on insulin receptor signaling - Toward understanding the insulin-like properties of camel milk. Front Endocrinol (Lausanne) 2016,7(JAN),4","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"17516","DOI":"10.1038\/s41598-019-53933-5","volume":"9","author":"Macierzanka A.","year":"2019","unstructured":"Macierzanka A.; Mackie A.R.; Krupa L.; Permeability of the small intestinal mucus for physiologically relevant studies: Impact of mucus location and ex vivo treatment. Sci Rep 2019,9(1),17516","journal-title":"Sci Rep"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1007\/s11095-014-1614-x","volume":"32","author":"Havelund S.","year":"2015","unstructured":"Havelund S.; Ribel U.; Hub\u00e1lek F.; Hoeg-Jensen T.; Wahlund P.O.; Jonassen I.; Investigation of the physico-chemical properties that enable co-formulation of basal insulin degludec with fast-acting insulin aspart. Pharm Res 2015,32(7),2250-2258","journal-title":"Pharm Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jconrel.2020.07.037","volume":"327","author":"Vaidya A.","year":"2020","unstructured":"Vaidya A.; Mitragotri S.; Ionic liquid-mediated delivery of insulin to buccal mucosa. J Control Release 2020,327(May),26-34","journal-title":"J Control Release"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jconrel.2018.08.042","volume":"288","author":"Chen X.","year":"2018","unstructured":"Chen X.; Wang L.; Yu H.; Li C.; Feng J.; Haq F.; Khan A.; Khan R.U.; Preparation, properties and challenges of the microneedles-based insulin delivery system. J Control Release 2018,288,173-188","journal-title":"J Control Release"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/jphp.12607","volume":"68","author":"Wong C.Y.","year":"2016","unstructured":"Wong C.Y.; Martinez J.; Dass C.R.; Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities. J Pharm Pharmacol 2016,68(9),1093-1108","journal-title":"J Pharm Pharmacol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/apha.12460","volume":"213","author":"Salunkhe V.A.","year":"2015","unstructured":"Salunkhe V.A.; Esguerra J.L.S.; Ofori J.K.; Mollet I.G.; Braun M.; Stoffel M.; Wendt A.; Eliasson L.; Modulation of microRNA-375 expression alters voltage-gated Na(+) channel properties and exocytosis in insulin-secreting cells. Acta Physiol (Oxf) 2015,213(4),882-892","journal-title":"Acta Physiol (Oxf)"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"101731","DOI":"10.1016\/j.jddst.2020.101731","volume":"57","author":"Pandey S.S.","year":"2020","unstructured":"Pandey S.S.; Patel M.A.; Desai D.T.; Patel H.P.; Gupta A.R.; Joshi S.V.; Bioavailability enhancement of repaglinide from transdermally applied nanostructured lipid carrier gel\u202f: Optimization, in vitro and in vivo studies. J Drug Deliv Sci Technol 2020,57(March),101731","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=17","first-page":"84","volume":"7","author":"Sadhasivam L","year":"2015","unstructured":"Sadhasivam L; Dey N; Francis AP; Devasena T; Transdermal patches of chitosan nanoparticles for insulin delivery. International Journal of Pharmacy and Pharmaceutical Sciences 2015,7(5),84-88","journal-title":"International Journal of Pharmacy and Pharmaceutical Sciences"},{"key":"ref=18","first-page":"34","author":"Shah D.","year":"2016","unstructured":"Shah D.; Agrawal V.; Parikh R.; Noninvasive Insulin Delivery System\u202f: A review International Journal of Applied Pharmaceutics NONINVASIVE INSULIN DELIVERY SYSTEM. RE:view 2016(August),34-40","journal-title":"RE:view"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/17425247.2019.1551874","volume":"16","author":"Sabu C.","year":"2019","unstructured":"Sabu C.; Mufeedha P.; Pramod K.; Yeast-inspired drug delivery: Biotechnology meets bioengineering and synthetic biology. Expert Opin Drug Deliv 2019,16(1),27-41","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","volume":"165-166","author":"Pandit R.","year":"2020","unstructured":"Pandit R.; Chen L.; G\u00f6tz J.; The blood-brain barrier: Physiology and strategies for drug delivery. Adv Drug Deliv Rev 2020,165-166,1-14","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","volume":"31","author":"Patel M.M.","year":"2017","unstructured":"Patel M.M.; Patel B.M.; Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain. CNS Drugs 2017,31(2),109-133","journal-title":"CNS Drugs"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.ijpharm.2019.01.056","volume":"559","author":"Sharma G.","year":"2019","unstructured":"Sharma G.; Sharma A.R.; Lee S.S.; Bhattacharya M.; Nam J.S.; Chakraborty C.; Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier. Int J Pharm 2019,559(559),360-372","journal-title":"Int J Pharm"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"Saraiva C.","year":"2016","unstructured":"Saraiva C.; Pra\u00e7a C.; Ferreira R.; Santos T.; Ferreira L.; Bernardino L.; Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release 2016,235,34-47","journal-title":"J Control Release"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.colsurfb.2015.01.035","volume":"127","author":"Sharma R.","year":"2015","unstructured":"Sharma R.; Gupta U.; Garg N.K.; Tyagi R.K.; Jain N.K.; Surface engineered and ligand anchored nanobioconjugate: an effective therapeutic approach for oral insulin delivery in experimental diabetic rats. Colloids Surf B Biointerfaces 2015,127,172-181","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph13100307","volume":"13","author":"Seyam S.","year":"2020","unstructured":"Seyam S.; Nordin N.A.; Alfatama M.; Recent progress of chitosan and chitosan derivatives-based nanoparticles: Pharmaceutical perspectives of oral insulin delivery. Pharmaceuticals (Basel) 2020,13(10),1-29","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.ijbiomac.2018.08.152","volume":"120","author":"Hu Q.","year":"2018","unstructured":"Hu Q.; Luo Y.; Recent advances of polysaccharide-based nanoparticles for oral insulin delivery. Int J Biol Macromol 2018,120(Pt A),775-782","journal-title":"Int J Biol Macromol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/jphp.12852","volume":"70","author":"Gedawy A.","year":"2018","unstructured":"Gedawy A.; Martinez J.; Al-Salami H.; Dass C.R.; Oral insulin delivery: existing barriers and current counter-strategies. J Pharm Pharmacol 2018,70(2),197-213","journal-title":"J Pharm Pharmacol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"100898","DOI":"10.1016\/j.nantod.2020.100898","volume":"34","author":"Vedadghavami A.","year":"2020","unstructured":"Vedadghavami A.; Zhang C.; Bajpayee A.G.; Overcoming negatively charged tissue barriers: Drug delivery using cationic peptides and proteins. Nano Today 2020,34,100898","journal-title":"Nano Today"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.msec.2017.04.113","volume":"78","author":"Xu B.","year":"2017","unstructured":"Xu B.; Jiang G.; Yu W.; Liu D.; Liu Y.; Kong X.; Yao J.; Preparation of poly(lactic-co-glycolic acid) and chitosan composite nanocarriers via electrostatic self assembly for oral delivery of insulin. Mater Sci Eng C 2017,78,420-428","journal-title":"Mater Sci Eng C"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40005-017-0374-0","volume":"48","author":"Ghosh D.","year":"2018","unstructured":"Ghosh D.; Peng X.; Leal J.; Mohanty R.; Peptides as drug delivery vehicles across biological barriers. J Pharm Investig 2018,48(1),89-111","journal-title":"J Pharm Investig"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejpb.2015.02.014","volume":"95","author":"Hidalgo A.","year":"2015","unstructured":"Hidalgo A.; Cruz A.; P\u00e9rez-Gil J.; Barrier or carrier? Pulmonary surfactant and drug delivery. Eur J Pharm Biopharm 2015,95(Pt A),117-127","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=32","first-page":"8","volume":"5","author":"Eraga SO","year":"2016","unstructured":"Eraga SO; Ovu EO; Iarhewoh M; An investigation of the properties of mucin obtained from three sources. The Pharma Innovation Journal 2016,5(12),8-12","journal-title":"The Pharma Innovation Journal"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrd.2015.21","volume":"15","author":"Banks W.A.","year":"2016","unstructured":"Banks W.A.; From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov 2016,15(4),275-292","journal-title":"Nat Rev Drug Discov"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4155\/ppa.15.34","volume":"4","author":"Pathak PP","year":"2015","unstructured":"Pathak PP; Oral insulin-delivery system for diabetes mellitus. Pharm Pat Anal 2015,4(1),29-36","journal-title":"Pharm Pat Anal"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.biomaterials.2016.06.059","volume":"103","author":"Lee J.H.","year":"2016","unstructured":"Lee J.H.; Sahu A.; Choi W.I.; Lee J.Y.; Tae G.; ZOT-derived peptide and chitosan functionalized nanocarrier for oral delivery of protein drug. Biomaterials 2016,103,160-169","journal-title":"Biomaterials"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijbiomac.2020.02.079","volume":"150","author":"Sudhakar S.","year":"2020","unstructured":"Sudhakar S.; Chandran S.V.; Selvamurugan N.; Nazeer R.A.; Biodistribution and pharmacokinetics of thiolated chitosan nanoparticles for oral delivery of insulin in vivo . Int J Biol Macromol 2020,150,281-288","journal-title":"Int J Biol Macromol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","volume":"13","author":"Pardridge W.M.","year":"2016","unstructured":"Pardridge W.M.; CSF, blood-brain barrier, and brain drug delivery. Expert Opin Drug Deliv 2016,13(7),963-975","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/marc.201700413","volume":"38","author":"Xie J.","year":"2017","unstructured":"Xie J.; Li A.; Li J.; Advances in pH-Sensitive Polymers for Smart Insulin Delivery. Macromol Rapid Commun 2017,38(23),1-14","journal-title":"Macromol Rapid Commun"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1080\/10717544.2018.1501119","volume":"25","author":"Reinholz J.","year":"2018","unstructured":"Reinholz J.; Landfester K.; Mail\u00e4nder V.; The challenges of oral drug delivery via nanocarriers. Drug Deliv 2018,25(1),1694-1705","journal-title":"Drug Deliv"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1517\/17425247.2015.1018175","volume":"12","author":"Pridgen E.M.","year":"2015","unstructured":"Pridgen E.M.; Alexis F.; Farokhzad O.C.; Polymeric nanoparticle drug delivery technologies for oral delivery applications. Expert Opin Drug Deliv 2015,12(9),1459-1473","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/17425247.2019.1605353","volume":"16","author":"Maghrebi S.","year":"2019","unstructured":"Maghrebi S.; Prestidge C.A.; Joyce P.; An update on polymer-lipid hybrid systems for improving oral drug delivery. Expert Opin Drug Deliv 2019,16(5),507-524","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/17425247.2018.1420050","volume":"15","author":"Sgorla D.","year":"2018","unstructured":"Sgorla D.; Lechanteur A.; Almeida A.; Sousa F.; Melo E.; Bunhak \u00c9.; Mainardes R.; Khalil N.; Cavalcanti O.; Sarmento B.; Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery. Expert Opin Drug Deliv 2018,15(3),213-222","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"9690","DOI":"10.1039\/C8NJ01375F","volume":"42","author":"Lajevardi A.","year":"2018","unstructured":"Lajevardi A.; Hossaini Sadr M.; Tavakkoli Yaraki M.; Badiei A.; Armaghan M.; A pH-responsive and magnetic Fe3O4@silica@MIL-100(Fe)\/&#x3B2;-CD nanocomposite as a drug nanocarrier: Loading and release study of cephalexin. New J Chem 2018,42(12),9690-9701","journal-title":"New J Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1016\/j.apt.2020.08.011","volume":"31","author":"Akbarzadeh I.","year":"2020","unstructured":"Akbarzadeh I.; Tavakkoli Yaraki M.; Ahmadi S.; Chiani M.; Nourouzian D.; Folic acid-functionalized niosomal nanoparticles for selective dual-drug delivery into breast cancer cells: An in-vitro investigation. Adv Powder Technol 2020,31(9),4064-4071","journal-title":"Adv Powder Technol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijpharm.2018.02.045","volume":"542","author":"Czuba E.","year":"2018","unstructured":"Czuba E.; Diop M.; Mura C.; Schaschkow A.; Langlois A.; Bietiger W.; Neidl R.; Virciglio A.; Auberval N.; Julien-David D.; Maillard E.; Frere Y.; Marchioni E.; Pinget M.; Sigrist S.; Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system. Int J Pharm 2018,542(1-2),47-55","journal-title":"Int J Pharm"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1517\/17425247.2016.1151872","volume":"13","author":"Rao S.","year":"2016","unstructured":"Rao S.; Prestidge C.A.; Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery. Expert Opin Drug Deliv 2016,13(5),691-707","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11010-017-3147-1","volume":"439","author":"Deveci H.A.","year":"2018","unstructured":"Deveci H.A.; Naz\u0131ro\u011flu M.; Nur G.; 5-Fluorouracil-induced mitochondrial oxidative cytotoxicity and apoptosis are increased in MCF-7 human breast cancer cells by TRPV1 channel activation but not Hypericum perforatum treatment. Mol Cell Biochem 2018,439(1-2),189-198","journal-title":"Mol Cell Biochem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1080\/10799893.2017.1369121","volume":"37","author":"Nur G.","year":"2017","unstructured":"Nur G.; Naz\u0131ro\u011flu M.; Deveci H.A.; Synergic prooxidant, apoptotic and TRPV1 channel activator effects of alpha-lipoic acid and cisplatin in MCF-7 breast cancer cells. J Recept Signal Transduct 2017,37(6),569-577","journal-title":"J Recept Signal Transduct"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e03650","DOI":"10.1016\/j.heliyon.2020.e03650","volume":"6","author":"Momoh M.A.","year":"2020","unstructured":"Momoh M.A.; Franklin K.C.; Agbo C.P.; Ugwu C.E.; Adedokun M.O.; Anthony O.C.; Chidozie O.E.; Okorie A.N.; Microemulsion-based approach for oral delivery of insulin: formulation design and characterization. Heliyon 2020,6(3),e03650","journal-title":"Heliyon"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ijpharm.2017.06.052","volume":"528","author":"El-Say K.M.","year":"2017","unstructured":"El-Say K.M.; El-Sawy H.S.; Polymeric nanoparticles: Promising platform for drug delivery. Int J Pharm 2017,528(1-2),675-691","journal-title":"Int J Pharm"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.msec.2015.11.067","volume":"60","author":"Masood F.","year":"2016","unstructured":"Masood F.; Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Mater Sci Eng C 2016,60,569-578","journal-title":"Mater Sci Eng C"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.msec.2017.02.115","volume":"75","author":"Kamari Y.","year":"2017","unstructured":"Kamari Y.; Ghiaci P.; Ghiaci M.; Study on montmorillonite\/insulin\/TiO hybrid nanocomposite as a new oral drug-delivery system. Mater Sci Eng C 2017,75,822-828","journal-title":"Mater Sci Eng C"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/02652048.2019.1604846","volume":"36","author":"Chen T.","year":"2019","unstructured":"Chen T.; Li S.; Zhu W.; Liang Z.; Zeng Q.; Self-assembly pH-sensitive chitosan\/alginate coated polyelectrolyte complexes for oral delivery of insulin. J Microencapsul 2019,36(1),96-107","journal-title":"J Microencapsul"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jconrel.2016.02.031","volume":"227","author":"Alibolandi M.","year":"2016","unstructured":"Alibolandi M.; Alabdollah F.; Sadeghi F.; Mohammadi M.; Abnous K.; Ramezani M.; Hadizadeh F.; Dextran-b-poly(lactide- co-glycolide) polymersome for oral delivery of insulin: In vitro and in vivo evaluation. J Control Release 2016,227,58-70","journal-title":"J Control Release"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.msec.2016.08.083","volume":"70","author":"Li L.","year":"2017","unstructured":"Li L.; Jiang G.; Yu W.; Liu D.; Chen H.; Liu Y.; Tong Z.; Kong X.; Yao J.; Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin. Mater Sci Eng C 2017,70(Pt 1),278-286","journal-title":"Mater Sci Eng C"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ijpharm.2015.05.065","volume":"491","author":"Diop M.","year":"2015","unstructured":"Diop M.; Auberval N.; Viciglio A.; Langlois A.; Bietiger W.; Mura C.; Peronet C.; Bekel A.; Julien David D.; Zhao M.; Pinget M.; Jeandidier N.; Vauthier C.; Marchioni E.; Frere Y.; Sigrist S.; Design, characterisation, and bioefficiency of insulin- chitosan nanoparticles after stabilisation by freeze-drying or cross-linking. Int J Pharm 2015,491(1-2),402-408","journal-title":"Int J Pharm"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijpharm.2015.02.055","volume":"484","author":"Yu F.","year":"2015","unstructured":"Yu F.; Li Y.; Liu C.S.; Chen Q.; Wang G.H.; Guo W.; Wu X.E.; Li D.H.; Wu W.D.; Chen X.D.; Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin. Int J Pharm 2015,484(1-2),181-191","journal-title":"Int J Pharm"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/mp400507g","volume":"11","year":"2014","unstructured":"Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles. Mol Pharm 2014,11(3),808-18","journal-title":"Mol Pharm"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejpb.2012.10.003","volume":"83","author":"Antunes F.","year":"2013","unstructured":"Antunes F.; Andrade F.; Ara\u00fajo F.; Ferreira D.; Sarmento B.; Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs. Eur J Pharm Biopharm 2013,83(3),427-435","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.addr.2016.07.007","volume":"106","author":"Lundquist P.","year":"2016","unstructured":"Lundquist P.; Artursson P.; Oral absorption of peptides and nanoparticles across the human intestine: Opportunities, limitations and studies in human tissues. Adv Drug Deliv Rev 2016,106(Pt B),256-276","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0168-3659(99)00073-5","volume":"60","author":"Zambaux M.F.","year":"1999","unstructured":"Zambaux M.F.; Bonneaux F.; Gref R.; Dellacherie E.; Vigneron C.; Preparation and characterization of protein C-loaded PLA nanoparticles. J Control Release 1999,60(2-3),179-188","journal-title":"J Control Release"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/B:PHAM.0000012150.60180.e3","volume":"21","author":"Smith J.","year":"2004","unstructured":"Smith J.; Wood E.; Dornish M.; Effect of chitosan on epithelial cell tight junctions. Pharm Res 2004,21(1),43-49","journal-title":"Pharm Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0168-3659(99)00048-6","volume":"62","author":"Kawashima Y.","year":"1999","unstructured":"Kawashima Y.; Yamamoto H.; Takeuchi H.; Fujioka S.; Hino T.; Pulmonary delivery of insulin with nebulized DL-lactide\/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. J Control Release 1999,62(1-2),279-287","journal-title":"J Control Release"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"8608","DOI":"10.1039\/C4TB01374C","volume":"2","author":"Yang C.","year":"2014","unstructured":"Yang C.; Gao S.; Kjems J.; Folic acid conjugated chitosan for targeted delivery of siRNA to activated macrophages in vitro and in vivo. J Mater Chem B Mater Biol Med 2014,2(48),8608-8615","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jcis.2018.04.025","volume":"524","author":"Massaro M.","year":"2018","unstructured":"Massaro M.; Cavallaro G.; Colletti C.G.; D\u2019Azzo G.; Guernelli S.; Lazzara G.; Pieraccini S.; Riela S.; Halloysite nanotubes for efficient loading, stabilization and controlled release of insulin. J Colloid Interface Sci 2018,524,156-164","journal-title":"J Colloid Interface Sci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"116594","DOI":"10.1016\/j.carbpol.2020.116594","volume":"247","author":"Sarkar S.","year":"2020","unstructured":"Sarkar S.; Das D.; Dutta P.; Kalita J.; Wann S.B.; Manna P.; Chitosan: A promising therapeutic agent and effective drug delivery system in managing diabetes mellitus. Carbohydr Polym 2020,247(June),116594","journal-title":"Carbohydr Polym"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ejps.2010.12.007","volume":"42","author":"Makhlof A.","year":"2011","unstructured":"Makhlof A.; Tozuka Y.; Takeuchi H.; Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 2011,42(5),445-451","journal-title":"Eur J Pharm Sci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s13346-019-00620-7","volume":"9","author":"Mallawarachchi S.","year":"2019","unstructured":"Mallawarachchi S.; Mahadevan A.; Gejji V.; Fernando S.; Mechanics of controlled release of insulin entrapped in polyacrylic acid gels via variable electrical stimuli. Drug Deliv Transl Res 2019,9(4),783-794","journal-title":"Drug Deliv Transl Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jconrel.2008.09.073","volume":"133","author":"Cohen-Sela E.","year":"2009","unstructured":"Cohen-Sela E.; Chorny M.; Koroukhov N.; Danenberg H.D.; Golomb G.; A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. J Control Release 2009,133(2),90-95","journal-title":"J Control Release"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.2217\/nnm.12.31","volume":"7","author":"Jain S.","year":"2012","unstructured":"Jain S.; Rathi V.V.; Jain A.K.; Das M.; Godugu C.; Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Nanomedicine (Lond) 2012,7(9),1311-1337","journal-title":"Nanomedicine (Lond)"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.foodhyd.2006.11.008","volume":"22","author":"Liu X.Y.","year":"2008","unstructured":"Liu X.Y.; Wang Q.; Cui S.W.; Liu H.Z.; A new isolation method of \u03b2-d-glucans from spent yeast Saccharomyces cerevisiae. Food Hydrocoll 2008,22(2),239-247","journal-title":"Food Hydrocoll"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"10011","DOI":"10.2147\/CMAR.S218668","volume":"11","author":"Ibrahim A.B.","year":"2019","unstructured":"Ibrahim A.B.; Zaki H.F.; Wadie W.; Omran M.M.; Shouman S.A.; Simvastatin evokes an unpredicted antagonism for tamoxifen in MCF-7 breast cancer cells. Cancer Manag Res 2019,11,10011-10028","journal-title":"Cancer Manag Res"},{"key":"ref=73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.10.024","author":"J\u00f8rgensen J.R.","year":"2020","unstructured":"J\u00f8rgensen J.R.; Thamdrup L.H.E.; Kamguyan K.; Nielsen L.H.; Nielsen H.M.; Boisen A.; Design of a self-unfolding delivery concept for oral administration of macromolecules. J Control Release 2020","journal-title":"J Control Release"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"119888","DOI":"10.1016\/j.ijpharm.2020.119888","volume":"590","author":"Appleton S.L.","year":"2020","unstructured":"Appleton S.L.; Tannous M.; Argenziano M.; Muntoni E.; Rosa A.C.; Rossi D.; Caldera F.; Scomparin A.; Trotta F.; Cavalli R.; Nanosponges as protein delivery systems: Insulin, a case study. Int J Pharm 2020,590(May),119888","journal-title":"Int J Pharm"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.mattod.2017.05.006","volume":"20","author":"Zhang X.","year":"2017","unstructured":"Zhang X.; Xu X.; Chen Y.; Dou Y.; Zhou X.; Li L.; Bioinspired yeast microcapsules loaded with self-assembled nanotherapies for targeted treatment of cardiovascular disease. Mater Today 2017,20(6),301-313","journal-title":"Mater Today"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3389\/fnins.2019.00629","volume":"13","author":"Gabbouj S.","year":"2019","unstructured":"Gabbouj S.; Ryh\u00e4nen S.; Marttinen M.; Wittrahm R.; Takalo M.; Kemppainen S.; Martiskainen H.; Tanila H.; Haapasalo A.; Hiltunen M.; Natunen T.; Altered insulin signaling in Alzheimer\u2019s disease brain-special emphasis on pi3k-akt pathway. Front Neurosci 2019,13(JUN),629","journal-title":"Front Neurosci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2015.12.054","volume":"224","author":"Kenngott E.E.","year":"2016","unstructured":"Kenngott E.E.; Kiefer R.; Schneider-Daum N.; Hamann A.; Schneider M.; Schmitt M.J.; Breinig F.; Surface-modified yeast cells: A novel eukaryotic carrier for oral application. J Control Release 2016,224,1-7","journal-title":"J Control Release"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"955","DOI":"10.2217\/nnm-2017-0059","volume":"12","author":"Hu X.","year":"2017","unstructured":"Hu X.; Zhang J.; Yeast capsules for targeted delivery: the future of nanotherapy? Nanomedicine (Lond) 2017,12(9),955-957","journal-title":"Nanomedicine (Lond)"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s10295-012-1193-y","volume":"39","author":"Kregiel D.","year":"2012","unstructured":"Kregiel D.; Berlowska J.; Szubzda B.; Novel permittivity test for determination of yeast surface charge and flocculation abilities. J Ind Microbiol Biotechnol 2012,39(12),1881-1886","journal-title":"J Ind Microbiol Biotechnol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijpharm.2011.02.047","volume":"409","author":"Qi X.","year":"2011","unstructured":"Qi X.; Wang L.; Zhu J.; Hu Z.; Zhang J.; Self-double-emulsifying drug delivery system (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeability. Int J Pharm 2011,409(1-2),245-251","journal-title":"Int J Pharm"},{"key":"ref=81","doi-asserted-by":"publisher","DOI":"10.1186\/2008-2231-21-73","volume":"21","author":"Salari R","year":"2013","unstructured":"Salari R; Sedigheh B; Bazzaz F; Rajabi O; Khashyarmanesh Z.; New aspects of Saccharomyces cerevisiae as a novel carrier for berberine. Daru 2013,21(1)","journal-title":"Daru"},{"key":"ref=82","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.6b04523","author":"Zhou X","year":"2017","unstructured":"Zhou X; Zhang X; Han S; Dou Y; Liu M; Zhang L; Yeast microcapsule-mediated targeted delivery of diverse nanoparticles for imaging and therapy via the oral route. Nano Lett 2017","journal-title":"Nano Lett"},{"key":"ref=83","first-page":"4502","volume":"80","author":"Shi L.","year":"2014","unstructured":"Shi L.; Li Z.; Tachikawa H.; Gao X.;  Use of Yeast Spores for Microencapsulation of Enzymes 2014,80(15),4502-4510","journal-title":"Use of Yeast Spores for Microencapsulation of Enzymes"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jfda.2015.01.007","volume":"23","author":"Alai M.S.","year":"2015","unstructured":"Alai M.S.; Lin W.J.; Pingale S.S.; Application of polymeric nanoparticles and micelles in insulin oral delivery. J Food Drug Anal 2015,23(3),351-358","journal-title":"J Food Drug Anal"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"8589","DOI":"10.1039\/c3sm51538a","volume":"9","author":"Yang H.","year":"2013","unstructured":"Yang H.; Sun X.; Liu G.; Ma R.; Li Z.; An Y.; Glucose-responsive complex micelles for self-regulated release of insulin under physiological conditions. Soft Matter 2013,9(35),8589-8599","journal-title":"Soft Matter"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"9826","DOI":"10.1016\/j.biomaterials.2011.08.087","volume":"32","author":"Chen M.C.","year":"2011","unstructured":"Chen M.C.; Sonaje K.; Chen K.J.; Sung H.W.; A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery. Biomaterials 2011,32(36),9826-9838","journal-title":"Biomaterials"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.biomaterials.2008.12.066","volume":"30","author":"Sonaje K.","year":"2009","unstructured":"Sonaje K.; Lin Y.H.; Juang J.H.; Wey S.P.; Chen C.T.; Sung H.W.; \nIn vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 2009,30(12),2329-2339","journal-title":"Biomaterials"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.addr.2013.04.006","volume":"65","author":"Bakhru S.H.","year":"2013","unstructured":"Bakhru S.H.; Furtado S.; Morello A.P.; Mathiowitz E.; Oral delivery of proteins by biodegradable nanoparticles. Adv Drug Deliv Rev 2013,65(6),811-821","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","volume":"55","author":"Panyam J.","year":"2003","unstructured":"Panyam J.; Labhasetwar V.; Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003,55(3),329-347","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ddtec.2005.05.019","volume":"2","author":"Florence A.T.","year":"2005","unstructured":"Florence A.T.; Nanoparticle uptake by the oral route: Fulfilling its potential? Drug Discov Today Technol 2005,2(1),75-81","journal-title":"Drug Discov Today Technol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jconrel.2012.03.022","volume":"164","author":"Florence A.T.","year":"2012","unstructured":"Florence A.T.; \u201cTargeting\u201d nanoparticles: the constraints of physical laws and physical barriers. J Control Release 2012,164(2),115-124","journal-title":"J Control Release"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jddst.2016.10.010","volume":"36","author":"Erel G.","year":"2016","unstructured":"Erel G.; Kotmak\u00e7\u0131 M.; Akbaba H.; S\u00f6zer Karada\u011fl\u0131 S.; Kantarc\u0131 A.G.; Nanoencapsulated chitosan nanoparticles in emulsion-based oral delivery system: In vitro and in vivo evaluation of insulin loaded formulation. J Drug Deliv Sci Technol 2016,36,161-167","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ejps.2008.01.013","volume":"33","author":"Graf A.","year":"2008","unstructured":"Graf A.; Jack K.S.; Whittaker A.K.; Hook S.M.; Rades T.; Protein delivery using nanoparticles based on microemulsions with different structure-types. Eur J Pharm Sci 2008,33(4-5),434-444","journal-title":"Eur J Pharm Sci"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejpb.2010.07.002","volume":"76","author":"Sharma G.","year":"2010","unstructured":"Sharma G.; Wilson K.; van der Walle C.F.; Sattar N.; Petrie J.R.; Ravi Kumar M.N.V.; Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats. Eur J Pharm Biopharm 2010,76(2),159-169","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"118772","DOI":"10.1016\/j.ijpharm.2019.118772","volume":"573","author":"Visetvichaporn V.","year":"2020","unstructured":"Visetvichaporn V.; Kim K.H.; Jung K.; Cho Y.S.; Kim D.D.; Formulation of self-microemulsifying drug delivery system (SMEDDS) by D-optimal mixture design to enhance the oral bioavailability of a new cathepsin K inhibitor (HL235). Int J Pharm 2020,573(June),118772","journal-title":"Int J Pharm"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0378-5173(03)00315-6","volume":"262","author":"Attama A.A.","year":"2003","unstructured":"Attama A.A.; Nzekwe I.T.; Nnamani P.O.; Adikwu M.U.; Onugu C.O.; The use of solid self-emulsifying systems in the delivery of diclofenac. Int J Pharm 2003,262(1-2),23-28","journal-title":"Int J Pharm"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ejps.2003.08.005","volume":"20","author":"Odeberg J.M.","year":"2003","unstructured":"Odeberg J.M.; Kaufmann P.; Kroon K.G.; H\u00f6glund P.; Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine. Eur J Pharm Sci 2003,20(4-5),375-382","journal-title":"Eur J Pharm Sci"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/B978-0-12-814487-9.00009-0","author":"Rajpoot K.","year":"2020","unstructured":"Rajpoot K.; Tekade M.; Pandey V.; Nagaraja S.; Youngren-ortiz S.R.; Tekade R.K.; System\u202f: Ongoing challenges and future ahead. Drug Delivery Systems 2020,393-454","journal-title":"Drug Delivery Systems"},{"key":"ref=99","first-page":"99","volume":"29","author":"Choi J-H.","year":"1999","unstructured":"Choi J-H.; Kim J-Y.; Ku Y-S.; Self-Emulsifying Drug Delivery System Containing Ibuprofen for Oral Use. J Pharm Investig 1999,29(2),99-103","journal-title":"J Pharm Investig"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/03639040500216428","volume":"31","author":"Wei L","year":"2005","unstructured":"Wei L; Sun P.; Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev Ind Pharm 2005,31(8),785-794","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/10611860290022688","volume":"10","author":"Eaimtrakarn S.","year":"2002","unstructured":"Eaimtrakarn S.; Rama Prasad Y.V.; Ohno T.; Konishi T.; Yoshikawa Y.; Shibata N.; Takada K.; Absorption enhancing effect of labrasol on the intestinal absorption of insulin in rats. J Drug Target 2002,10(3),255-260","journal-title":"J Drug Target"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1002\/jps.23757","volume":"102","author":"Friedl H.","year":"2013","unstructured":"Friedl H.; D\u00fcnnhaupt S.; Hintzen F.; Waldner C.; Parikh S.; Pearson J.P.; Wilcox M.D.; Bernkop-Schn\u00fcrch A.; Development and evaluation of a novel mucus diffusion test system approved by self-nanoemulsifying drug delivery systems. J Pharm Sci 2013,102(12),4406-4413","journal-title":"J Pharm Sci"},{"key":"ref=103","first-page":"88","volume":"46","author":"Mohsin K.","year":"2012","unstructured":"Mohsin K.; Shahba A.A.; Alanazi F.K.; Lipid based self emulsifying formulations for poorly water soluble drugs-An excellent opportunity. Indian J Pharm Educ Res 2012,46(2),88-96","journal-title":"Indian J Pharm Educ Res"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijpharm.2009.11.026","volume":"386","author":"Ruan J.","year":"2010","unstructured":"Ruan J.; Liu J.; Zhu D.; Gong T.; Yang F.; Hao X.; Zhang Z.; Preparation and evaluation of self-nanoemulsified drug delivery systems (SNEDDSs) of matrine based on drug-phospholipid complex technique. Int J Pharm 2010,386(1-2),282-290","journal-title":"Int J Pharm"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1166\/jbn.2012.1371","volume":"8","author":"Zhang Q.","year":"2012","unstructured":"Zhang Q.; He N.; Zhang L.; Zhu F.; Chen Q.; Qin Y.; Zhang Z.; Zhang Q.; Wang S.; He Q.; The in vitro and in vivo study on self-nanoemulsifying drug delivery system (SNEDDS) based on insulin-phospholipid complex. J Biomed Nanotechnol 2012,8(1),90-97","journal-title":"J Biomed Nanotechnol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ijbiomac.2020.02.275","volume":"152","author":"Batool A.","year":"2020","unstructured":"Batool A.; Arshad R.; Razzaq S.; Nousheen K.; Kiani M.H.; Shahnaz G.; Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer. Int J Biol Macromol 2020,152,503-515","journal-title":"Int J Biol Macromol"},{"key":"ref=107","author":"Boyd AP","year":"2001","unstructured":"Boyd AP; Cornelis GUYR; Yersinia. 2001"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1099\/mic.0.2008\/021162-0","volume":"154","author":"Martinez-Argudo I.","year":"2008","unstructured":"Martinez-Argudo I.; Jepson M.A.; Salmonella translocates across an in vitro M cell model independently of SPI-1 and SPI-2. Microbiology 2008,154(Pt 12),3887-3894","journal-title":"Microbiology"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.1090124","volume":"304","author":"Cossart P","year":"2004","unstructured":"Cossart P; Sansonetti PJ; Bacterial invasion: The paradigms of enteroinvasive pathogens. Science (80- ) 2004,304(5668),242-248","journal-title":"Science (80- )"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ejps.2006.12.006","volume":"30","author":"des Rieux A.","year":"2007","unstructured":"des Rieux A.; Fievez V.; Th\u00e9ate I.; Mast J.; Pr\u00e9at V.; Schneider Y.J.; An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells. Eur J Pharm Sci 2007,30(5),380-391","journal-title":"Eur J Pharm Sci"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/emboj.2008.38","volume":"27","author":"Amstutz B.","year":"2008","unstructured":"Amstutz B.; Gastaldelli M.; K\u00e4lin S.; Imelli N.; Boucke K.; Wandeler E.; Mercer J.; Hemmi S.; Greber U.F.; Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3. EMBO J 2008,27(7),956-969","journal-title":"EMBO J"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.devcel.2006.04.002","volume":"10","author":"Macia E.","year":"2006","unstructured":"Macia E.; Ehrlich M.; Massol R.; Boucrot E.; Brunner C.; Kirchhausen T.; Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 2006,10(6),839-850","journal-title":"Dev Cell"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.colsurfb.2017.10.037","volume":"161","author":"Shi Y.","year":"2018","unstructured":"Shi Y.; Xue J.; Jia L.; Du Q.; Niu J.; Zhang D.; Surface-modified PLGA nanoparticles with chitosan for oral delivery of tolbutamide. Colloids Surf B Biointerfaces 2018,161,67-72","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"113352","DOI":"10.1016\/j.molliq.2020.113352","volume":"311","author":"Khair R.","year":"2020","unstructured":"Khair R.; Shende P.; Kulkarni Y.A.; Nanostructured polymer-based cochleates for effective transportation of insulin. J Mol Liq 2020,311,113352","journal-title":"J Mol Liq"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"41322","DOI":"10.1038\/srep41322","volume":"7","author":"Liu M.","year":"2017","unstructured":"Liu M.; Zhong X.; Yang Z.; Chitosan functionalized nanocochleates for enhanced oral absorption of cyclosporine A. Sci Rep 2017,7,41322","journal-title":"Sci Rep"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3109\/08982104.2016.1149865","volume":"27","author":"Nagarsekar K.","year":"2017","unstructured":"Nagarsekar K.; Ashtikar M.; Steiniger F.; Thamm J.; Schacher F.H.; Fahr A.; Micro-spherical cochleate composites: method development for monodispersed cochleate system. J Liposome Res 2017,27(1),32-40","journal-title":"J Liposome Res"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"81188","DOI":"10.1039\/C5RA08550K","volume":"5","author":"Pawar A.","year":"2015","unstructured":"Pawar A.; Bothiraja C.; Shaikh K.; Mali A.; An insight into cochleates, a potential drug delivery system. RSC Advances 2015,5(99),81188-81202","journal-title":"RSC Advances"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.apsusc.2017.11.055","volume":"2018","author":"Samed N.","year":"2010","unstructured":"Samed N.; Sharma V.; Sundaramurthy A.; Hydrogen bonded niosomes for encapsulation and release of hydrophilic and hydrophobic anti-diabetic drugs: An efficient system for oral anti-diabetic formulation. Appl Surf Sci 2010,2018(449),567-573","journal-title":"Appl Surf Sci"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cis.2013.11.018","volume":"205","author":"Marianecci C.","year":"2014","unstructured":"Marianecci C.; Di Marzio L.; Rinaldi F.; Celia C.; Paolino D.; Alhaique F.; Esposito S.; Carafa M.; Niosomes from 80s to present: the state of the art. Adv Colloid Interface Sci 2014,205,187-206","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics12111001","volume":"12","author":"Yanar F.","year":"2020","unstructured":"Yanar F.; Mosayyebi A.; Nastruzzi C.; Carugo D.; Zhang X.; Continuous\u2010flow production of liposomes with a millireactor under varying fluidic conditions. Pharmaceutics 2020,12(11),1-21","journal-title":"Pharmaceutics"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.apsb.2011.09.002","volume":"1","author":"Kumar G.P.","year":"2011","unstructured":"Kumar G.P.; Rajeshwarrao P.; Nonionic surfactant vesicular systems for effective drug delivery\u2014an overview. Acta Pharm Sin B 2011,1(4),208-219","journal-title":"Acta Pharm Sin B"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"118580","DOI":"10.1016\/j.ijpharm.2019.118580","volume":"569","author":"Ghafelehbashi R.","year":"2019","unstructured":"Ghafelehbashi R.; Akbarzadeh I.; Tavakkoli Yaraki M.; Lajevardi A.; Fatemizadeh M.; Heidarpoor Saremi L.; Preparation, physicochemical properties, in vitro evaluation and release behavior of cephalexin-loaded niosomes. Int J Pharm 2019,569(July),118580","journal-title":"Int J Pharm"},{"key":"ref=123","first-page":"108","volume":"15","author":"Loona S.","year":"2012","unstructured":"Loona S.; Gupta N.B.; Khan M.U.; Preparation and characterization of metformin proniosomal gel for treatment of diabetes mellitus. Int J Pharm Sci Rev Res 2012,15(2),108-114","journal-title":"Int J Pharm Sci Rev Res"},{"key":"ref=124","first-page":"653","author":"Capozzi A","year":"2012","unstructured":"Capozzi A; Mantuano E; Matarrese P; Saccomanni G; Manera C; Mattei V; A New 4-phenyl-1,8-naphthyridine derivative affects carcinoma cell proliferation by impairing cell cycle progression and inducing apoptosis. 2012,653-662"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"E1367","DOI":"10.3390\/foods9101367","volume":"9","author":"Estupi\u00f1an O.R.","year":"2020","unstructured":"Estupi\u00f1an O.R.; Garcia-Manrique P.; Blanco-Lopez M.D.C.; Matos M.; Guti\u00e9rrez G.; Vitamin d3 loaded niosomes and transfersomes produced by ethanol injection method: Identification of the critical preparation step for size control. Foods 2020,9(10),E1367","journal-title":"Foods"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.3390\/pharmaceutics11020055","volume":"11","author":"Ge X.","year":"2019","unstructured":"Ge X.; Wei M.; He S.; Yuan W.E.; Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics 2019,11(2),E55","journal-title":"Pharmaceutics"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.biotechadv.2015.02.010","volume":"33","author":"Fonte P.","year":"2015","unstructured":"Fonte P.; Ara\u00fajo F.; Silva C.; Pereira C.; Reis S.; Santos H.A.; Sarmento B.; Polymer-based nanoparticles for oral insulin delivery: Revisited approaches. Biotechnol Adv 2015,33(6 Pt 3),1342-1354","journal-title":"Biotechnol Adv"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201818666210720145706","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/194941\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201818666210720145706","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:49:39Z","timestamp":1671274179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/194941\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":127,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201818666210720145706","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}